Prehospital use of dexamethasone in pulseless idioventricular rhythm

Paul M. Paris; Ronald D. Stewart; Frank Deggler

doi:10.1016/S0196-0644(84)80059-1

Prehospital use of dexamethasone in pulseless idioventricular rhythm

Paul M. Paris, Ronald D. Stewart, Frank Deggler

Résultat de recherche: Article › examen par les pairs

31 Citations (Scopus)

Résumé

We investigated the prehospital use of 100 mg dexamethasone for the treatment of cardiac arrest patients with pulseless idioventricular rhythms (PIVR). In the 86 patients studied in this prospective, randomized, double-blind investigation, four of the 46 patients receiving saline and two of the 37 patients receiving dexamethasone survived long enough to be admitted to the hospital intensive care unit. There were no long-term survivors. No benefit from the field use of 100 mg dexamethasone in PIVR could be identified in this study.

Langue d'origine	English
Pages (de-à)	1008-1010
Nombre de pages	3
Journal	Annals of Emergency Medicine
Volume	13
Numéro de publication	11
DOI	https://doi.org/10.1016/S0196-0644(84)80059-1
Statut de publication	Published - nov. 1984
Publié à l'externe	Oui

Note bibliographique

Funding Information:
The authors gratefully acknowledge fiscal support from Organon Pharmaceuticals and the cooperation of Director Glenn Cannon and the personnel of the City of Pittsburgh Emergency Medical Services Department.

ASJC Scopus Subject Areas

Emergency Medicine

PubMed: MeSH publication types

Clinical Trial
Journal Article

Accès au document

10.1016/S0196-0644(84)80059-1

Autres fichiers et liens

Citer

@article{1e8ef9a6e2074a83bfbed0e6b7c0a4d0,

title = "Prehospital use of dexamethasone in pulseless idioventricular rhythm",

abstract = "We investigated the prehospital use of 100 mg dexamethasone for the treatment of cardiac arrest patients with pulseless idioventricular rhythms (PIVR). In the 86 patients studied in this prospective, randomized, double-blind investigation, four of the 46 patients receiving saline and two of the 37 patients receiving dexamethasone survived long enough to be admitted to the hospital intensive care unit. There were no long-term survivors. No benefit from the field use of 100 mg dexamethasone in PIVR could be identified in this study.",

author = "Paris, {Paul M.} and Stewart, {Ronald D.} and Frank Deggler",

note = "Funding Information: The authors gratefully acknowledge fiscal support from Organon Pharmaceuticals and the cooperation of Director Glenn Cannon and the personnel of the City of Pittsburgh Emergency Medical Services Department.",

year = "1984",

month = nov,

doi = "10.1016/S0196-0644(84)80059-1",

language = "English",

volume = "13",

pages = "1008--1010",

journal = "Annals of Emergency Medicine",

issn = "0196-0644",

publisher = "Mosby Inc.",

number = "11",

}

TY - JOUR

T1 - Prehospital use of dexamethasone in pulseless idioventricular rhythm

AU - Paris, Paul M.

AU - Stewart, Ronald D.

AU - Deggler, Frank

N1 - Funding Information: The authors gratefully acknowledge fiscal support from Organon Pharmaceuticals and the cooperation of Director Glenn Cannon and the personnel of the City of Pittsburgh Emergency Medical Services Department.

PY - 1984/11

Y1 - 1984/11

N2 - We investigated the prehospital use of 100 mg dexamethasone for the treatment of cardiac arrest patients with pulseless idioventricular rhythms (PIVR). In the 86 patients studied in this prospective, randomized, double-blind investigation, four of the 46 patients receiving saline and two of the 37 patients receiving dexamethasone survived long enough to be admitted to the hospital intensive care unit. There were no long-term survivors. No benefit from the field use of 100 mg dexamethasone in PIVR could be identified in this study.

AB - We investigated the prehospital use of 100 mg dexamethasone for the treatment of cardiac arrest patients with pulseless idioventricular rhythms (PIVR). In the 86 patients studied in this prospective, randomized, double-blind investigation, four of the 46 patients receiving saline and two of the 37 patients receiving dexamethasone survived long enough to be admitted to the hospital intensive care unit. There were no long-term survivors. No benefit from the field use of 100 mg dexamethasone in PIVR could be identified in this study.

UR - http://www.scopus.com/inward/record.url?scp=0021733978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021733978&partnerID=8YFLogxK

U2 - 10.1016/S0196-0644(84)80059-1

DO - 10.1016/S0196-0644(84)80059-1

M3 - Article

C2 - 6385785

AN - SCOPUS:0021733978

SN - 0196-0644

VL - 13

SP - 1008

EP - 1010

JO - Annals of Emergency Medicine

JF - Annals of Emergency Medicine

IS - 11

ER -

Prehospital use of dexamethasone in pulseless idioventricular rhythm

Résumé

Note bibliographique

ASJC Scopus Subject Areas

PubMed: MeSH publication types

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer